Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 240.25B |
| Revenue (ttm) | 43.74B |
| Net Income (ttm) | 6.57B |
| Shares Out | 375.71M |
| EPS (ttm) | 17.32 |
| PE Ratio | 36.93 |
| Forward PE | 26.58 |
| Dividend | $1.72 (0.27%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 2,621,506 |
| Open | 637.39 |
| Previous Close | 636.30 |
| Day's Range | 634.81 - 643.99 |
| 52-Week Range | 385.46 - 643.99 |
| Beta | 0.91 |
| Analysts | Strong Buy |
| Price Target | 637.78 (-0.26%) |
| Earnings Date | Jan 29, 2026 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for TMO stock is "Strong Buy." The 12-month stock price target is $637.78, which is a decrease of -0.26% from the latest price.
News
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Thermo Fisher wins contracts as pharma shifts production to US, CEO says
Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move production from Europe or Asia to the U.S., the medical equipment maker's CEO, Marc...
Nalgene Outdoor Unveils Thrill & Motion: A High-Energy Color Collection for 2026
ROCHESTER, N.Y.--(BUSINESS WIRE)--Nalgene Outdoor today introduces Thrill & Motion, a dynamic new collection crafted for people who embrace an active, on-the-go lifestyle; whether exploring trails, ch...
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laborat...
Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company
Thermo Fisher Scientific's number-two executive, Michel Lagarde, is leaving the life-sciences giant to pursue another opportunity.
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific launches CorEvitas Obesity Registry to advance real-world evidence in treatment outcomes.
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full ye...
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care.
OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy
LOS ANGELES--(BUSINESS WIRE)--OlivePoint acquires a Class A Raleigh office 100% leased to PPD/Thermo Fisher, highlighting its strategy to target mispriced, credit-backed assets.
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (...
Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack
The Investment Committee debate the latest Calls of the Day.
Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitm...
Top 15 High-Growth Dividend Stocks For December 2025
The Top 15 High-Growth Dividend Stocks for December 2025 offer a 1.58% yield and 20.97% five-year dividend growth, appearing 33% undervalued. The watchlist's goal is a 12% long-term CAGR, with Novembe...
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) ...
Josh Brown's ‘best stocks in the market': Health Care
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's spotlighting Health Care in his "best stocks in the market." The Committee debates their health care s...
Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ ...
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing*
WALTHAM, Mass.--(BUSINESS WIRE)--To support the quality of beverage products, Thermo Fisher Scientific today introduced the Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay**, an in...
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Cente...
Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (M...
Artisan Value Fund Q3 2025 Top Contributors And Detractors
Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo. On the positive side, the three new purchases we...
Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway
The Investment Committee give you their top stocks to watch for the second half.
The Big 3: TMO, DHR, VLO
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi...
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GA...